Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00410553
Status:
COMPLETED
Last Update Posted:
2018-10-03
First Post:
2006-12-11
Brief Title:
Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Uterine Corpus Cancer AJCC v7 |
| Adult Solid Neoplasm |
| Recurrent Ovarian Carcinoma |
| Recurrent Uterine Corpus Carcinoma |
| Stage III Ovarian Cancer AJCC v6 and v7 |
| Stage III Uterine Corpus Cancer AJCC v7 |
| Stage IV Ovarian Cancer AJCC v6 and v7 |
Keywords: